Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

Overview of attention for article published in BMC Cancer, May 2009

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 65 Dimensions

Readers on

mendeley: 82 Mendeley
connotea: 1 Connotea

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

CIGB-300 FOR USE IN THE THE INDUCTION OF ANTITUMOR AND ANTIVIRAL IMMUNTY

Application WO-2022127945-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.